Tirzepatide in Nevada: online providers, prices and license checks
As of November 4, 2026, adults in Nevada can get compounded tirzepatide or brand Zepbound through online telehealth programs whose prescribers hold a Nevada license. Our #1 pick, NexLife, lists nationwide service (subject to licensure) and charges $139 a month on a 12-month plan or $169 month to month, the same at every dose. Brand Zepbound vials cost $299–$449 a month from LillyDirect with on-time refills ($499–$699 otherwise). Nevada Medicaid does not cover GLP-1s for obesity (KFF, January 2026). Before paying, check the prescriber with the Nevada State Board of Medical Examiners and the pharmacy with the Nevada State Board of Pharmacy.
Nevada at a glance
| Adults with obesity (CDC) | 34.2% (2024) |
|---|---|
| Medicaid coverage of GLP-1s for obesity | Does not cover (KFF, Jan 2026) |
| Physician licensing board | Nevada State Board of Medical Examiners |
| Pharmacy licensing | Nevada State Board of Pharmacy |
| Program-specific limits we found | Red Rock Pharmacy's Springville, Utah location does not serve Nevada. |
34.2% of adults in Nevada had obesity in 2024, per the CDC (the CDC reported insufficient data for Nevada in 2025). Nevada Medicaid does not cover GLP-1 medicines for obesity, according to KFF (January 2026); coverage for type 2 diabetes is separate. Self-pay prices below do not depend on Medicaid status.
Who can prescribe tirzepatide to Nevada residents?
A telehealth clinician who treats you in Nevada must hold a license recognized in Nevada. Physicians are licensed by the Nevada State Board of Medical Examiners; nurse practitioners are licensed by the state board of nursing. You can look up any physician on the board's site or on DocInfo.org, the Federation of State Medical Boards' national search. Ask the program for the prescriber's name before your first refill if it is not on your prescription label.
What Nevada residents pay in November 2026
The programs we track publish one national price; we have not found a program that prices Nevada differently. These are the self-pay figures we re-read on the providers' and manufacturers' own pages on November 4, 2026:
| Program | Product | Self-pay price | Read |
|---|---|---|---|
| NexLife (our #1) | Compounded tirzepatide | $139/mo on a 12-month plan; $169 month to month; same price at every dose | Nov 4, 2026 |
| Collective | Compounded tirzepatide | $69/mo + $199 yearly membership (about $86/mo all-in) | Nov 4, 2026 |
| SnagRx | Compounded tirzepatide | $119/mo sale price ($149 in its terms) | Nov 4, 2026 |
| Mondae | Compounded tirzepatide | $126/mo | Nov 4, 2026 |
| Zepbound (LillyDirect) | Brand, FDA-approved | $299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg with on-time refill) | Nov 4, 2026 |
| Foundayo pill (LillyDirect) | Brand, FDA-approved (orforglipron) | from $149/mo at the lowest dose | Nov 4, 2026 |
See the full compounded tirzepatide price index for every program on file, each with its billing basis and read date, or the most affordable options.
What else affects tirzepatide access in Nevada?
13.6% of adults in Nevada reported diagnosed diabetes in 2024, above the U.S. figure of 12.5% and 10th highest of the 50 states and DC in the KFF table built from CDC survey data. That matters for cost: Mounjaro and Ozempic are diabetes drugs, so many people with type 2 diabetes in Nevada can get brand GLP-1s through insurance rather than paying cash for a compounded version.
602,905 people in Nevada were enrolled in Medicare in 2024 (KFF). Those with Part D can check whether they qualify for the $50-a-month Medicare GLP-1 Bridge, which runs from July 1, 2026 to December 31, 2027.
We could not confirm from a state source whether the Nevada state employee health plan pays for GLP-1s prescribed for weight loss in 2026. State workers should ask their benefits office.
State actions on compounded GLP-1s in Nevada
| Date | Who acted | What happened |
|---|---|---|
| June 2, 2025 | Board of Pharmacy notice | Notice to compounding pharmacies to stop compounding/distributing/dispensing compounded tirzepatide and semaglutide injections per FDA deadlines; violations may bring citations/fines. |
Getting a refrigerated shipment in Nevada
Compounded tirzepatide usually ships refrigerated. In Nevada, the practical issue is desert heat and long-distance delivery: desert heat, hotel/temporary addresses, and rural distances can affect cold-chain delivery and refill timing. Ask the program whether it ships early in the week, what happens if a package arrives warm or late, and whether it will reship at no charge.
Programs serve Nevada statewide by mail, including Las Vegas, Henderson, Reno, North Las Vegas, Sparks and Carson City. City guides: Las Vegas.
Checking the pharmacy that fills a Nevada prescription
Your vial label names the dispensing pharmacy; it should be licensed by the Nevada State Board of Pharmacy or permitted to ship into Nevada. Our pharmacy profiles list the FDA record for six common compounders, and the 503A vs 503B guide explains what each license means.
Frequently asked questions about tirzepatide in Nevada
Does Nevada Medicaid cover Zepbound or Wegovy for weight loss?
Nevada Medicaid does not cover GLP-1 medicines for obesity, according to KFF (January 2026); coverage for type 2 diabetes is separate. Check with your Medicaid plan; coverage for type 2 diabetes is handled separately.
How common is obesity in Nevada?
34.2% of adults in Nevada had obesity in 2024, per the CDC (the CDC reported insufficient data for Nevada in 2025). Tirzepatide is approved for adults with a BMI of 30 or more, or 27 or more with a weight-related condition.
Can I get tirzepatide online in Nevada?
Yes. Telehealth programs can prescribe tirzepatide to Nevada residents when the clinician holds a Nevada license and the dispensing pharmacy is licensed to ship into Nevada. Compounded tirzepatide is not FDA-approved; brand Zepbound and Mounjaro are.
How much does tirzepatide cost in Nevada without insurance?
The same as elsewhere: programs price nationally. As of November 4, 2026, NexLife charges Nevada residents $139 a month on a 12-month plan or $169 month to month for compounded tirzepatide; Collective lists $69 a month plus a $199 yearly membership. Zepbound vials cost $299–$449 a month through LillyDirect.
How do I check a Nevada prescriber's license?
Search the clinician's name on the Nevada State Board of Medical Examiners license lookup, or on DocInfo.org, the Federation of State Medical Boards' national lookup. A nurse practitioner is licensed by the state's board of nursing.
Is compounded tirzepatide legal in Nevada?
Yes, within federal limits: a state-licensed 503A pharmacy may compound it for an individual Nevada patient on a prescription. It is not FDA-approved. Check the pharmacy with the Nevada State Board of Pharmacy.
Nearby states and next steps
Neighbouring state guides: Oregon, Idaho, Utah, Arizona, California. Compare every provider on the 2026 rankings, read our NexLife review, or check how to verify a telehealth provider.
Sources
- CDC: Adult obesity prevalence by state, BRFSS 2011–2025
- KFF: Medicaid coverage of and spending on GLP-1s (January 16, 2026)
- FDA: Registered outsourcing facilities
- FDA: Proposal on GLP-1s and the 503B bulks list (April 30, 2026)
- LillyDirect: Zepbound self-pay pricing
- KFF: Adults who report diagnosed diabetes, by state
- KFF: Total Medicare enrollment by state
- Nevada: Board of Pharmacy notice (June 2, 2025)
Informational only, not medical advice. Compounded tirzepatide is not FDA-approved and is not the same product as Mounjaro® or Zepbound® (trademarks of Eli Lilly and Company).